707 related articles for article (PubMed ID: 28044273)
1. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.
Puzari M; Chetia P
World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273
[TBL] [Abstract][Full Text] [Related]
2. Biochemical Reconstitution and Characterization of Multicomponent Drug Efflux Transporters.
Picard M; Tikhonova EB; Broutin I; Lu S; Verchère A; Zgurskaya HI
Methods Mol Biol; 2018; 1700():113-145. PubMed ID: 29177829
[TBL] [Abstract][Full Text] [Related]
3. Molecular Modeling of Multidrug Properties of Resistance Nodulation Division (RND) Transporters.
Cacciotto P; Ramaswamy VK; Malloci G; Ruggerone P; Vargiu AV
Methods Mol Biol; 2018; 1700():179-219. PubMed ID: 29177832
[TBL] [Abstract][Full Text] [Related]
4. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
5. MexAB-OprM Efflux Pump Interaction with the Peptidoglycan of
Ma M; Lustig M; Salem M; Mengin-Lecreulx D; Phan G; Broutin I
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070225
[TBL] [Abstract][Full Text] [Related]
6. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
[TBL] [Abstract][Full Text] [Related]
7. Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria.
Tikhonova EB; Wang Q; Zgurskaya HI
J Bacteriol; 2002 Dec; 184(23):6499-507. PubMed ID: 12426337
[TBL] [Abstract][Full Text] [Related]
8. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.
Srikumar R; Kon T; Gotoh N; Poole K
Antimicrob Agents Chemother; 1998 Jan; 42(1):65-71. PubMed ID: 9449262
[TBL] [Abstract][Full Text] [Related]
9. Efflux pump-mediated antibiotics resistance: insights from computational structural biology.
Fischer N; Raunest M; Schmidt TH; Koch DC; Kandt C
Interdiscip Sci; 2014 Mar; 6(1):1-12. PubMed ID: 24464699
[TBL] [Abstract][Full Text] [Related]
10. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
11. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae.
Weston N; Sharma P; Ricci V; Piddock LJV
Res Microbiol; 2018; 169(7-8):425-431. PubMed ID: 29128373
[TBL] [Abstract][Full Text] [Related]
14. A model of a transmembrane drug-efflux pump from Gram-negative bacteria.
Fernandez-Recio J; Walas F; Federici L; Venkatesh Pratap J; Bavro VN; Miguel RN; Mizuguchi K; Luisi B
FEBS Lett; 2004 Dec; 578(1-2):5-9. PubMed ID: 15581607
[TBL] [Abstract][Full Text] [Related]
15. Directed evolution of a bacterial efflux pump: adaptation of the E. coli TolC exit duct to the Pseudomonas MexAB translocase.
Bokma E; Koronakis E; Lobedanz S; Hughes C; Koronakis V
FEBS Lett; 2006 Oct; 580(22):5339-43. PubMed ID: 16979625
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
[TBL] [Abstract][Full Text] [Related]
17. Tripartite assembly of RND multidrug efflux pumps.
Daury L; Orange F; Taveau JC; Verchère A; Monlezun L; Gounou C; Marreddy RK; Picard M; Broutin I; Pos KM; Lambert O
Nat Commun; 2016 Feb; 7():10731. PubMed ID: 26867482
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.
Gotoh N; Murata T; Ozaki T; Kimura T; Kondo A; Nishino T
J Infect Chemother; 2003 Mar; 9(1):101-3. PubMed ID: 12673418
[TBL] [Abstract][Full Text] [Related]
19. A periplasmic coiled-coil interface underlying TolC recruitment and the assembly of bacterial drug efflux pumps.
Lobedanz S; Bokma E; Symmons MF; Koronakis E; Hughes C; Koronakis V
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4612-7. PubMed ID: 17360572
[TBL] [Abstract][Full Text] [Related]
20. [Bacterial efflux pumps - their role in antibiotic resistance and potential inhibitors].
Hricová K; Kolář M
Klin Mikrobiol Infekc Lek; 2014 Dec; 20(4):116-20. PubMed ID: 25702054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
